Studies have shown that with the progression of breast cancer, the positive rate of Cav-3 in epithelial tissues decreases, while the positive rate of Cav-2 in interstitial tissues increases (Koo et al., 2011). This evidence concerns the gene CAV2 and breast carcinoma.